Entertainment

SMU Leads Singapore-Indonesia Educational Collaboration Through RI-SING University Network

SINGAPORE,Nov. 18,2024--The Singapore Management University(SMU) hosted the third RI-SING University Network (RUN) meeting on 12-13 November 2024,bringing together top educational leaders from Singap

11-19 Singapore Management University (SMU)

AV-Comparatives Releases 2024 Advanced Threat Protection Test Results for Enterprise Cybersecurity Solutions

Helping CISOs Select Top-Performing Cybersecurity Solutions with Rigorous Advanced Threat Protection Testing Results for 2024

11-19 AV-Comparatives

WELLlife COVID-19/Influenza A&B Home Test on Sale for Black Friday and Cyber Monday

BOLINGBROOK,Ill.,Nov. 18,2024--Stock up your family\'s medicine cabinet this Black Friday and Cyber Monday. WELLlife,a leading innovator in medical diagnostic and testing solutions,is increasing acces

11-19 WELLlife

Two-Day Countdown - Hong Kong Fashion Fest kicks off a city-wide celebration of fashion, culture and creativity

HONG KONG,Nov. 19,2024-- The highly anticipated Hong Kong FashionFest,running from 20 November to 4 December 2024,is set to take over the city with an expansive programme celebrating fashion,creativi

11-19 Cultural and Creative Industries Development Agency (CCIDA)

Telix to Add FAP-Targeting Candidates to Theranostic Pipeline

MELBOURNE,Australia,Nov. 19,2024-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces it will expand its theranostic pipeline with new assets targeting Fibroblast

11-19 Telix Pharmaceuticals Limited

FinVolution Group Reports Third Quarter 2024 Unaudited Financial Results

-Third Quarter Total Transaction Volume reached RMB52.2 billion,up 1.8% year-over-year- -Third Quarter International Transaction Volume reached RMB2.7 billion,up 22.7% year-over-year-

11-19 FinVolution Group

Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Conver

78-Week results from Phase III randomized controlled trial (RCT) including switching data from reference denosumab to CT-P41 (biosimilar candidate of denosumab) demonstrate comparable efficacy and sa

11-19 Celltrion USA

G20's focus on development highlights the contributions of the 'Global South': Global Times editorial

BEIJING,Nov. 19,2024-- The 19th G20 Summit is being held in Rio de Janeiro,Brazil,from November 18 to 19. Chinese PresidentXi Jinping said at the summit that China has announced the decision to give a

11-19 Global Times

GHIT Fund Awarded Open Philanthropy Grant to Expand Funding Sources for Global Health R&D

TOKYO,Nov. 19,2024--The Global Health Innovative Technology (GHIT) Fundis pleased to announce that Open Philanthropy,a grantmaking organization based in San Francisco,California,has awarded funding fo

11-19 Global Health Innovative Technology Fund (GHIT Fund)

Indonesia Unveils the Secret Colour of Mandalika, A Journey to Lombok's Enchanting Sites and Traditions

LOMBOK,Indonesia,Nov. 15,2024-- The Indonesian Ministry of Tourism and Creative Economy proudly unveils its latest promotional video,"The Secret Colour of Mandalika",inviting international t

11-18 Indonesia's Ministry of Tourism and Creative Economy